https://universalproject.org/penta-coordinates-new-european-african-project-that-will-develop-universal-treatments-for-children-living-with-hiv/ 2021-05-27T10:25:45+00:00 https://universalproject.org/wp-content/uploads/2021/04/UNIVERSAL-INSTAGRAM-LINKEDIN-FACEBOOK-805x503-1.png https://universalproject.org/the-birth-of-universal-project-a-back-story/ 2021-06-24T08:38:01+00:00 https://universalproject.org/wp-content/uploads/2021/06/UNIVERSAL.jpg https://universalproject.org/unitaid-chai-laurus-labs-to-accelerate-development-of-best-in-class-hiv-medication-for-children/ 2021-10-12T07:39:48+00:00 https://universalproject.org/wp-content/uploads/2021/10/Untitled-design-4.jpg https://universalproject.org/capacitating-the-future-of-research-in-paediatric-hiv/ 2022-05-25T10:45:43+00:00 https://universalproject.org/wp-content/uploads/2022/04/Untitled-design.png https://universalproject.org/wp-content/uploads/2022/04/respondents-by-county.png https://universalproject.org/wp-content/uploads/2022/04/priotity-needs.png https://universalproject.org/dr-awa-kane-md/ 2022-10-03T13:13:32+00:00 https://universalproject.org/wp-content/uploads/2022/09/3.png https://universalproject.org/nakamyuka-rashidah/ 2022-10-03T13:14:18+00:00 https://universalproject.org/wp-content/uploads/2022/09/1.png https://universalproject.org/caroline-angel-nansubuga/ 2022-10-03T13:14:25+00:00 https://universalproject.org/wp-content/uploads/2022/09/4.png https://universalproject.org/get-to-know-the-universal-project-assessing-the-long-term-safety-of-art-drugs/ 2023-01-09T10:19:40+00:00 https://universalproject.org/wp-content/uploads/2022/12/UNIVERSAL-WP-5.png https://universalproject.org/get-to-know-the-universal-project-relative-bioavailability-study-pk-sub-study/ 2023-03-29T12:19:18+00:00 https://universalproject.org/wp-content/uploads/2023/03/Get-to-know-UNIVERSAL-1.png https://universalproject.org/get-to-know-the-universal-project-pharmacokinetic-study-of-new-dtg-ftc-taf-dose-ratio/ 2023-03-29T12:36:49+00:00 https://universalproject.org/wp-content/uploads/2023/01/UNIVERSAL-WP-3.png https://universalproject.org/universal-general-assembly-meeting-2023/ 2023-06-06T15:15:03+00:00 https://universalproject.org/wp-content/uploads/2023/06/86F32FBA-0087-4FC5-A2DD-F1E293BBCBBB_1_201_a.jpeg https://universalproject.org/inaugural-training-session-for-clinical-trial-management-course/ 2023-06-20T08:44:39+00:00 https://universalproject.org/wp-content/uploads/2023/06/UNIVERSAL-Inagural-course.png https://universalproject.org/gilead-partners-with-chai-and-penta-to-improve-treatment-and-adherence-rates-among-children-with-hiv-in-low-and-middle-income-countries/ 2023-07-17T08:13:52+00:00 https://universalproject.org/relative-bioavailability-of-dolutegravir-dtg-and-emtricitabine-tenofovir-alafenamide-fumarate-f-taf-administered-as-paediatric-tablet-formulations-in-healthy-volunteers/ 2023-09-18T08:06:08+00:00 https://universalproject.org/the-universal-projects-potential-impact-on-the-health-of-children-living-with-hiv-as-told-by-dr-vivian-mumbiro/ 2023-12-20T14:48:31+00:00 https://universalproject.org/wp-content/uploads/2023/12/Dr-V.png https://universalproject.org/universal-submits-data-to-the-fda-to-support-the-dosing-of-a-new-drug-combination-to-treat-hiv-in-children/ 2024-04-08T08:49:47+00:00 https://universalproject.org/wp-content/uploads/2024/03/%C2%A9-juran001Getty-Images-2.png https://universalproject.org/meet-the-winners-of-the-universal-student-research-capacity-building-and-cipher-grants/ 2024-05-02T06:35:31+00:00 https://universalproject.org/wp-content/uploads/2022/09/4.png https://universalproject.org/wp-content/uploads/2022/09/1.png https://universalproject.org/wp-content/uploads/2022/09/3.png https://universalproject.org/universal-data-supports-laurus-labs-us-fda-submission-for-approval-of-novel-protease-inhibitor/ 2024-09-04T09:04:20+00:00 https://universalproject.org/wp-content/uploads/2024/08/UNIVERSAL-Laur-Labs-1.png https://universalproject.org/optimising-paediatric-hiv-treatment-recent-developments-and-future-directions/ 2024-10-28T10:55:09+00:00 https://universalproject.org/universal-1-trial-enrols-first-patients/ 2025-01-14T10:39:23+00:00 https://universalproject.org/wp-content/uploads/2025/01/UNI-1-recruitment.png https://universalproject.org/efficacy-of-second-line-dolutegravir-versus-boosted-protease-inhibitor-based-art-in-children-and-adolescents-living-with-hiv-at-96-and-144-weeks-pooled-analysis-of-the-odyssey-and-chapas-4-trials/ 2025-07-17T08:39:36+00:00 https://universalproject.org/pharmacokinetics-of-a-novel-dose-ratio-of-dtg-ftc-taf-for-african-children-with-hiv-universal1/ 2026-03-03T15:06:57+00:00 https://universalproject.org/closing-the-paediatric-hiv-treatment-gap/ 2026-06-23T09:15:39+00:00 https://universalproject.org/wp-content/uploads/2026/06/UNIVERSAL-closing-peadiatric-HIV-gap.jpg https://universalproject.org/relative-bioavailability-of-dolutegravir-dtg-and-emtricitabine-tenofovir-alafenamide-fumarate-f-taf-administered-as-paediatric-tablet-formulations-in-healthy-volunteers-2/ 2026-07-20T06:22:24+00:00 https://universalproject.org/simulation-based-predictions-to-support-the-development-of-a-pediatric-fixed-dose-combination-of-dolutegravir-emtricitabine-tenofovir-alafenamide-fumarate/ 2026-08-10T07:22:12+00:00 https://universalproject.org/expediting-a-universal-first-line-regimen-of-a-dolutegravir-emtricitabine-tenofovir-alafenamide-fixed-dose-ratio-for-children-living-with-hiv-older-than-4-weeks-a-24-week-open-label/ 2026-09-10T08:35:45+00:00